Eyebright (Euphrasia) for Eye Tumors: Potential Benefits and Current Evidence

What Is Eyebright?

Euphrasia officinalis (eyebright) is a small flowering herb traditionally used in European folk medicine for eye inflammation, irritation, and fatigue. Recently, its phytochemicals have drawn interest for potential anticancer effects.

Key Bioactive Compounds

• Flavonoids (luteolin, apigenin): Antioxidant, anti-inflammatory.
• Phenolic acids (caffeic, rosmarinic acid): Antioxidant, possible antiproliferative effects.
• Iridoid glycosides (aucubin): Anti-inflammatory.
• Tannins: Astringent, antimicrobial.
• Anthocyanins: Antioxidant, give the plant its color.

Research Status

Laboratory Studies

In vitro and animal studies suggest eyebright extracts may inhibit growth of certain cancer cell lines, including some ocular tumors. Mechanisms include antioxidant activity, anti-inflammatory effects, and immune modulation.

Clinical Evidence

No human clinical trials have evaluated eyebright for eye tumors or any cancer. Traditional use is limited to topical eye washes for irritation.

Safety and Limitations

• Oral or topical use for cancer is not supported by clinical evidence.
• Eyebright may interact with medications or cause allergic reactions.
• Self-treating ocular tumors with herbal remedies risks delaying proven, sight- and life-saving treatments.

Conclusion

Eyebright shows intriguing preclinical activity, but it is not a validated cancer treatment. Patients with ocular tumors should follow their ophthalmologist/oncologist's recommendations and discuss any complementary therapies with their care team.